
EMJ: #1 open access destination for HCPs. Peer-reviewed journals & diverse content hub. Interviews, podcasts, webinars, infographics.
UK & Europe
Joined August 2011
- Tweets31.7K
- Following4.9K
- Followers11.4K
- Likes3.8K
Pinned Tweet
Join our mailing list for FREE to receive research breakthroughs, news and insights direct to your inbox: hubs.la/Q03pv6Bp0
As the @ESMO Congress 2026 gets underway in Madrid, the future of cancer care is firmly in focus.
From advancing AI in oncology to strengthening cancer prevention and care delivery, ESMO's latest strategic priorities reflect the evolving needs of the global oncology community.
Hear more from EMJ reporter Cecilia and follow our Congress coverage for the latest insights: hubs.la/Q04Cg40c0
#ESMO2026 #MedicalOncology #CancerResearch #OncologyInnovation
Let's get into your weekly news wrap:
📌 Global Dementia Cases Set to More Than Double by 2050: hubs.la/Q04C80260
📌 UK Government to Tighten Restrictions on High-Risk Cosmetic Procedures: hubs.la/Q04C80v60
📌 Medical Cannabis for Insomnia Shows Limited Benefits: hubs.la/Q04C80wn0
Could better blood pressure management save half a million lives every year?
New preliminary research estimates that improving hypertension control could prevent more than 518,000 cardiovascular deaths annually across 20 countries, highlighting the potential impact of expanding preventive care.
Explore the findings: hubs.la/Q04C395Y0
Older drivers with Type 2 diabetes showed slower braking responses in a driving simulator.
A study of adults aged 60–79 years found longer braking times among those with diabetes, regardless of whether they had peripheral neuropathy.
Read more: hubs.la/Q04C38l80
Your time is limited. The content you read should be worth it.
The EQOH Score shows whether ours is. HCPs score how our content helps them elevate patient outcomes - and right now, it stands at 9.4/10.
Learn more: hubs.la/Q04C8Gc10
In oncology, one new finding could change a treatment decision.
At the @myESMO 2026 congress, Madrid will bring together the latest evidence in immunotherapy, molecular diagnostics, targeted treatments, and AI, with potential implications across cancer care.
Keep up with EMJ Oncology throughout the congress: hubs.la/Q04C7Wzf0
Mitochondrial DNA copy number may offer new insights into cancer biology.
A multicancer analysis linked higher copy numbers to greater mutation burden, while lower levels were associated with increased expression of genes involved in tumor migration and invasion.
Further research is needed to establish clinical relevance.
Learn more: hubs.ly/Q04C373W0
Could celiac disease increase the risk of complications in people with Type 2 diabetes?
New research found that patients living with both conditions had higher risks of neuropathy, eye complications, and severe hyperglycemia compared with those with Type 2 diabetes alone.
Explore the findings: hubs.ly/Q04C35x60
Could psoriasis one day be prevented?
In the latest EMJ Podcast series, host Saranya Ravindran speaks with Professor Christopher Griffiths OBE, Emeritus Professor of Dermatology at The University of Manchester and Adjunct Professor of Dermatology at King’s College London, UK, about the evolution of psoriasis research and care.
Across a quickfire episode and three deep dives, they explore:
🔹 How psoriasis came to be understood as an immune-mediated inflammatory disease
🔹 How precision medicine, biologics, and real-world evidence are advancing care
🔹 How AI and global collaboration could shape the next decade of research.
🎧 Listen now: hubs.ly/Q04C2_QX0
What do a blue muffin and biomarkers have in common?
The Blue Muffin Test uses non-absorbable blue dye to estimate gut transit time by tracking when blue stool first appears.
At #UEGW2026, researchers explored its potential as a population-level biomarker.
Read more: hubs.la/Q04C2ldr0
Can clinical trials and evolving treatment strategies change the outlook for acute myeloid leukaemia?
In the latest Hema Now episode, Charles Craddock, Professor of Haemato-oncology at the University of Warwick and Academic Director of the Centre for Clinical Haematology at University Hospitals Birmingham, UK, explores how AML treatment is evolving.
The discussion covers:
🔹 The changing role of stem cell transplantation
🔹 MRD-guided treatment and transplant decisions
🔹 Reduced-intensity conditioning and patient eligibility
🔹 Emerging therapies and the importance of stronger clinical trial infrastructure
🎧 Listen now: hubs.la/Q04BV8Vp0
Faster brain tumour diagnosis is coming to five NHS specialist centres.
Rapid genomic testing could speed access to treatment and clinical trials for the 13,000 people diagnosed each year in the UK.
Read more: hubs.la/Q04BG_DX0
Could the gut microbiome predict aggressive ulcerative colitis (UC)?
New research from #UEGW2026 suggests that gut microbiome profiling could help identify patients with newly diagnosed UC who are at risk of a more aggressive disease course.
Learn more: hubs.la/Q04BRTpX0
Let's get into your weekly news wrap:
📌 GLP-1s May Protect Against Stroke and Alzheimer's Disease: hubs.la/Q04BMDfs0
📌 Blood Pressure Control Could Prevent Half a Million Deaths Annually: hubs.la/Q04BMDbN0
📌 Early Look: MHRA 2030 Strategy - What You Need To Know: hubs.la/Q04BMD040
Respiratory care is changing fast. Will you be ahead of it?
In our new launch video, Helena Bradbury, Associate Editor at EMJ, unpacks why the latest edition of EMJ Respiratory is essential reading.
Here’s what’s inside:
- How one biologic cut COPD exacerbations by up to 34%
- Why breathlessness is about far more than the lungs
- What’s driving preventable pneumococcal deaths in Nigeria
Read it now: hubs.la/Q04BMC9p0
The UK government has announced a four-step plan to fast-track brain cancer research and treatment access.
It includes an expert review, a dedicated clinical lead, and an accelerated review of orphan drug rules.
Read more: hubs.la/Q04BGT7K0
For decades, COPD has been treated only once substantial, often irreversible lung damage has already occurred.
In this interview, Professor Borja Cosío explores the case for detecting disease earlier, targeting individual biology, and modifying its trajectory rather than just managing symptoms.
Read this ahead of tomorrow’s EMJ Respiratory journal release: hubs.la/Q04BBMRZ0
Playing Tetris for just 3 minutes was linked to a 13.9% reduction in craving strength.
A small real-world study found that the game helped reduce cravings for food, alcohol, nicotine, and other activities, highlighting the potential of visual distraction techniques.
Read more: hubs.la/Q04Bq4Zh0
COVID-19 infection has been linked to an increased risk of six allergic conditions.
A retrospective cohort study of children and adults aged 1–64 found higher rates of allergy diagnoses over an 18-month follow-up period.
Uncover more of the findings: hubs.la/Q04Bq4Gx0
Why are more people under 50 being diagnosed with cancer?
New figures reveal rising cases of seven cancer types among younger adults in England, with prostate cancer seeing the largest reported increase of 305% since 2001.
Explore the findings: hubs.la/Q04Bq3_c0












